GR3005747T3 - - Google Patents

Info

Publication number
GR3005747T3
GR3005747T3 GR920402073T GR920402073T GR3005747T3 GR 3005747 T3 GR3005747 T3 GR 3005747T3 GR 920402073 T GR920402073 T GR 920402073T GR 920402073 T GR920402073 T GR 920402073T GR 3005747 T3 GR3005747 T3 GR 3005747T3
Authority
GR
Greece
Prior art keywords
beta
alpha
cream formulation
ingredients
tipredane
Prior art date
Application number
GR920402073T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005747T3 publication Critical patent/GR3005747T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR920402073T 1987-11-13 1992-09-22 GR3005747T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/120,278 US4868169A (en) 1987-11-13 1987-11-13 Steroid cream formulation

Publications (1)

Publication Number Publication Date
GR3005747T3 true GR3005747T3 (enExample) 1993-06-07

Family

ID=22389294

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402073T GR3005747T3 (enExample) 1987-11-13 1992-09-22

Country Status (8)

Country Link
US (1) US4868169A (enExample)
EP (1) EP0316834B1 (enExample)
JP (1) JPH01153642A (enExample)
AT (1) ATE77553T1 (enExample)
CA (1) CA1326447C (enExample)
DE (1) DE3872354T2 (enExample)
ES (1) ES2042695T3 (enExample)
GR (1) GR3005747T3 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
GB9106365D0 (en) * 1991-03-26 1991-05-15 Bioglan Lab Ltd An emollient for use with ultraviolet light
DE59108924D1 (de) * 1991-07-16 1998-02-19 Schering Ag Verfahren zur herstellung von mikronisierte wirkstoffe enthaltende halbfeste zubereitungen
EP0675897B1 (en) * 1992-12-24 1997-06-18 Rhone-Poulenc Rorer Limited New steroids
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
CZ300146B6 (cs) * 1995-03-17 2009-02-25 Astrazeneca Uk Limited Sterilní vodná kompozice obsahující emulzi typu olej ve vode a edetát
US6846846B2 (en) * 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
US7745425B2 (en) * 2002-02-07 2010-06-29 The Trustees Of Columbia University In The City Of New York Non-irritating compositions containing zinc salts
CA2475224C (en) * 2002-02-07 2011-11-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
US7879365B2 (en) * 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
GB0219089D0 (en) * 2002-08-16 2002-09-25 Dow Corning Silicone foam control compositions
FR2844448B1 (fr) 2002-09-17 2006-06-23 Lcw Les Colorants Wackherr Methode de preparation extemporanee de compositions cosmetiques ayant la texture d'une creme, et compositions pour la mise en oeuvre de cette methode
BRPI0412675A (pt) * 2003-07-17 2006-10-03 Univ Columbia composições antimicrobianas contendo combinações sinergìsticas de compostos de amÈnio quaternário e óleos essenciais e/ou constituintes
US7759327B2 (en) 2006-01-06 2010-07-20 The Trustees Of Columbia University In The City Of New York Compositions containing zinc salts for coating medical articles
WO2007084789A2 (en) * 2006-01-20 2007-07-26 Wisconsin Alumni Research Foundation Method and apparatus for low dose computed tomography
US7801502B2 (en) * 2006-12-18 2010-09-21 Aai Corporation Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems
WO2010036620A2 (en) * 2008-09-29 2010-04-01 M-I L.L.C. Method and composition for determining hardness in wellbore fluid filtrate
US8409628B2 (en) 2010-02-04 2013-04-02 Penguin IP Holdings, Inc. Methods and compositions for oxygenation of skin to treat skin disorders
US8900601B2 (en) 2010-03-31 2014-12-02 Jennifer Bartels Permeable mixtures, methods and compositions for the skin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178345A (en) * 1964-01-20 1965-04-13 Upjohn Co Topical steroid composition
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
US4542129A (en) * 1982-08-16 1985-09-17 Norman Orentreich DHEA Formulations and methods for treating dry skin

Also Published As

Publication number Publication date
ATE77553T1 (de) 1992-07-15
DE3872354D1 (de) 1992-07-30
JPH01153642A (ja) 1989-06-15
US4868169A (en) 1989-09-19
CA1326447C (en) 1994-01-25
EP0316834A1 (en) 1989-05-24
ES2042695T3 (es) 1993-12-16
EP0316834B1 (en) 1992-06-24
DE3872354T2 (de) 1992-12-10

Similar Documents

Publication Publication Date Title
ATE77553T1 (de) Steroidcreme.
DE3470662D1 (en) Aqueous or anhydrous cosmetic composition containing a fatty phase based on karite oil
OA09034A (en) Anti-inflammatory cream composition
ES8703727A1 (es) Un metodo para preparar un producto ingerible de dulzor reducido.
ES2037759T3 (es) Concentrado de espuma de bano en forma de gel.
SG81882A1 (en) Retinoid composition
EP0009913A3 (en) Antacid composition, method of its manufacture and fondant mix comprising an antacid compound
FI854167A0 (fi) Mun- och tandvaordsmedel.
PT74928A (en) New anti-thromboticum based on polysachatides method for its preparation and pharmaceutical compositions
GB8528201D0 (en) Margarine &c fat compositions
AU5034879A (en) Acid addition salt of 2beta,16beta diperidino 5 alpha androstane derivatives
DE69202231D1 (de) Nicht-temperiertes Fett für Süsswaren.
ZA899670B (en) Phosphonic acid substituted steroids as steroid 5-alpha-reductase inhibitors
GR3005443T3 (enExample)
SE8800989L (sv) Dietkomposition samt foerfarande foer framstaellning av densamma
SE8800990L (sv) Hudregenererande kosmetisk komposition samt foerfarande foer framstaellning av densamma
NZ214107A (en) Method of increasing the ovulation rate or fecundity of sows by use of an immunogenic composition
SE8800988D0 (sv) Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same
DE3273193D1 (en) Cream base
JPS57171908A (en) Agent for preventing falling-out of hair, promoting growth and occurrence of hair
GB2010678B (en) Perfume ingredients and perfume compositions consisting of or containing 3,5,5-trimethylhexanoic acid esters
GB1487545A (en) Dermatological composition
DE69326075D1 (de) Verwendung von Zusammensetzungen essentieller Fettsäuren
JPS5449336A (en) Skin cream
Sadauskas et al. Comparison of the methods for terminating pregnancy